title: Influence of different isoforms of recombinant trophoblastic interferons on prostaglandin production in cultured bovine endometrial cells.
abstract: In ruminants, interferon produced by the trophectoderm (IFN-tau) is recognized as the embryonic signal responsible for maternal recognition of pregnancy. IFN-tau is believed to act by down-regulating estrogen receptors, thus preventing appearance of oxytocin receptors responsible for the release of prostaglandin F(2alpha) (PGF(2alpha)) by the endometrium. The present study was undertaken to determine in vitro the biological activities of different IFN-tau isoforms and document putative alternate luteotrophic mechanisms. Endometrial cells in primary cultures were treated with five different rIFN-tau isoforms: two ovine isoforms (ro-4 and ro-11) and three bovine isoforms (rb-1a, rb-2b and rb-3b). Their effect was quantified by measurement of PGE(2) and PGF(2alpha) production by ELISA and induction of cyclooxygenase (COX-2) by Western and Northern analysis and correlated with antiviral activity previously reported. The overall pattern of response to the IFNs tested suggests that low concentrations (<1 microg/ml) reduced the production of both PGs and higher concentrations (>1 microg/ml) stimulated preferentially PGE(2); however, exceptions were noted. Isoform rb-2b with high antiviral activity inhibited PG production in both cell types at all concentrations tested. IFNs rb-1a and ro-11 had similar antiviral activities, inhibiting PG at low concentrations and stimulating them at high concentrations. Isoform rb-3b stands out relative to the other IFNs tested because it induced a variable non-dose-dependent effect on PG production and low antiviral activity. An increase in COX-2 protein expression and messenger was correlated with increased PG production. The results showing two distinct responses to IFN-tau depending on its concentration and/or isoform and the absence of correlation with antiviral activity suggest that complex transduction mechanisms are involved.
authors.affiliation: Département d'Ontogénie et Reproduction, Centre de Recherches du Centre Hospitalier Universitaire de Québec (CHUL), Université Laval, Ste-Foy, Quebec, Canada G1V 4G2.
authors.forename: Julie
authors.initials: J
authors.lastname: Parent
authors.forename: Christian
authors.initials: C
authors.lastname: Villeneuve
authors.forename: Andrei P
authors.initials: AP
authors.lastname: Alexenko
authors.forename: Alan D
authors.initials: AD
authors.lastname: Ealy
authors.forename: Michel A
authors.initials: MA
authors.lastname: Fortier
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D002417:Cattle; D051546:Cyclooxygenase 2; D015237:Dinoprost / Q000096:biosynthesis*; D015232:Dinoprostone / Q000096:biosynthesis*; D004717:Endometrium / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D004790:Enzyme Induction / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D005260:Female; D007370:Interferon Type I / Q000494:pharmacology*; D007527:Isoenzymes / Q000096:biosynthesis; D010121:Oxytocin / Q000494:pharmacology; D011257:Pregnancy Proteins / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000096:biosynthesis; D020033:Protein Isoforms; D011994:Recombinant Proteins / Q000494:pharmacology; D017154:Stromal Cells / Q000187:drug effects / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D007370:Interferon Type I; D007527:Isoenzymes; D011257:Pregnancy Proteins; D020033:Protein Isoforms; D011994:Recombinant Proteins; C020947:interferon tau; D010121:Oxytocin; D015237:Dinoprost; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases; D015232:Dinoprostone; D013755:Tetradecanoylphorbol Acetate